Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers.

Authors
Type
Published Article
Journal
Cancer
1097-0142
Publisher
Wiley Blackwell (John Wiley & Sons)
Publication Date
Volume
117
Issue
14
Pages
3093–3100
Identifiers
DOI: 10.1002/cncr.25911
PMID: 21264845
Source
Medline
License
Unknown

Abstract

BRCA1 mutation carriers with TN disease had similar survival rates to noncarriers when treated with alkylating chemotherapy. Women with BRCA1-related breast cancer may benefit from novel therapies that target DNA repair, and further study is needed to identify sporadic TN breast cancers with a BRCA-deficient phenotype.

Statistics

Seen <100 times